EC 6.3.2.2), which catalyzes the formation of -glutamyl-cysteine, and glutathione synthase, which catalyzes the condensation of -glutamyl-cysteine and of glycine
Theyre also reshaping collective behaviorhow people eat, shop, move, perceive themselves, and make decisionswith significant implications for business leaders.
Ozempic, a glucagon-like peptide 1 (GLP-1) receptor agonist, was approved to treat type 2 diabetes in adults
Boshoff stated that Pfizer looks forward to contributing its expertise to continue the development of this investigational GLP-1 small molecule, noting that it complements and strengthens the companys growing portfolio of novel candidates for treating obesity and related diseases
At the time, the prevailing view was that obesity should be treated with lifestyle changes, and many of the weight-loss drugs on the market had raised safety concerns